Studies on Tobicillin, a New Antibiotic Drug for Enterococcicosis in Yellowtail Seriola quinqueradiata

Ooshima Takeo, Kaneda Shigeo, Ise Naomi, Okada Masaaki, Takagi Hirofumi

doi:10.2331/fishsci.63.741

Tobicillin (TBPC), an ester derivative of penicillin G (PCG), was examined as a treatment for enterococcicosis in yellowtail. After 6h at 25°C at pH 3, the residual rate of TBPC was over 80%, but that of PCG was only 20%. TBPC was stable in an acidic solution (pH 3). The area under the blood concentration-time curve (AUC) between 0 and 10h afteroral administration was about 7 times higher for TBPC (35.2 μg/ml•h) than that for PCG (5.2 μg/ml•h). In drug sensitivity tests using 156 strains of field-isolated Enterococcus seriolicida, the MICs of PCG were 0.39-0.78 μg/ml, and no strains were resistant to PCG. On the other hand, the MICs of erythromycin, lincomycin and oxytetracycline showed biphasic distributions that included both resistant and sensitive strains. In a preliminary evaluation of the efficacy of TBPC against experimental enterococcicosis in yellowtail, the cumulative death rate 5 days after infection was 56% for the non-treated group and 0% for the group treated with 100mg (potency)/kg/day. These results indicate that TBPC will be one of the effective antibiotics for the treatment of enterococcicosis in yellowtail.

Studies on Tobicillin, a New Antibiotic Drug for Enterococcicosis in Yellowtail <i>Seriola quinqueradiata</i>

Bibliographic Information

Search this article

Abstract

Journal

References(21)*help

Keywords

Details 詳細情報について

Export

Report a problem